MedPath

A study evaluating the Efficacy of Sub-Tenon Mitomycin C Trabeculectomy with and without Amniotic Membrane Transplantation as an Adjunct

Phase 4
Conditions
Health Condition 1: H403- Glaucoma secondary to eye traumaHealth Condition 2: O- Medical and SurgicalHealth Condition 3: H401- Open-angle glaucomaHealth Condition 4: H408- Other glaucomaHealth Condition 5: H402- Primary angle-closure glaucoma
Registration Number
CTRI/2024/04/065109
Lead Sponsor
Dr Siddhant Relekar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients of open-angle glaucoma and angle-closure glaucoma fulfilling the following criteria were included

1.IOP more than 21 mmHg despite using IOP-lowering medications

2.Patients willing for 3-month follow-up and investigations

Exclusion Criteria

A history of prior surgical interventions in the form of past glaucoma filtering surgery, cataract surgery, or any other surgery involving conjunctiva, or co-existing conjunctival disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study will provide further insight into the efficacy of amniotic membrane transplantation as an adjunct to sub-tenon Mitomycin trabeculectomyTimepoint: pre-operative <br/ ><br>post operative 3 month
Secondary Outcome Measures
NameTimeMethod
This study will provide further insight into the efficacy of amniotic membrane transplantation as an adjunct to sub-tenon Mitomycin trabeculectomyTimepoint: <br/ ><br>post operative day 1 <br/ ><br>post operative day 7
© Copyright 2025. All Rights Reserved by MedPath